Simplify Logo

Full-Time

Pioneering Medicines: Executive Director

In Vivo Pharmacology

Confirmed live in the last 24 hours

Flagship Pioneering

Flagship Pioneering

501-1,000 employees

Biotechnology firm creating health and sustainability solutions

Venture Capital

Expert

Cambridge, MA, USA

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • PhD in pharmacology or biological disciplines such as immunology, cellular biology, oncology, or biochemistry, with 10+ years direct pharmaceutical experience beyond postdoctoral work.
  • Experience in at least two of the following disease areas: immunology/inflammation, obesity, cardiovascular or oncology.
  • Deep pharmacology experience, particularly on the design of PK/PD studies.
  • A track record in driving projects along the developmental pipeline.
  • Ability to manage multiple projects and balance a broad set of priorities.
  • Demonstrated ability to lead teams to drive go/no go decisions.
  • Excellent project management skills and the ability to effectively manage CROs and to facilitate interactions with academic labs and companies to ensure project progression.
  • Direct experience in supporting IND strategy and documentation, including writing relevant pharmacology sections of INDs.
  • Flexibility to dynamically adapt workplans and lead teams through changing priorities and deadlines.
  • Ability to work both independently and collaboratively in a team-oriented, dynamic environment.
  • Excellent oral and written communication skills across all levels.
Responsibilities
  • Lead, manage and mentor the *in vivo* Pharmacology team.
  • Ensure leadership and oversight for development and implementation of *in vivo* preclinical efficacy, safety and PK/PD studies as well as *ex vivo* assays to support pharmacology studies.
  • Hands on contributions to the design, direction, execution, and analysis of pharmacological studies to advance candidates along the developmental pipeline.
  • Develop scientific and technical strategy to advance multiple projects in the pipeline.
  • Integrate data to provide a detailed understanding of the pharmacology of therapeutic proteins to enable understanding of in vitro MOAs and *in vivo* correlates of efficacy.
  • Identify, initiate, and manage productive collaborations with CROs and academic labs as appropriate to driving projects forward.
  • Proactively recognize and develop creative solutions for emerging technical and scientific issues.
  • Explore biomarker hypotheses using pre-clinical animal models.
  • Maintain scientific and technical expertise through familiarity with scientific literature.
  • Contribute to building a positive, team-oriented culture.

Flagship Pioneering fosters a culture of groundbreaking advancements in biotechnology, emphasizing an ecosystem approach that synergizes human health and sustainability. Their business model not only focuses on creating transformative products but also incubates leading companies like Moderna and Indigo Agriculture, positioning them at the forefront of scientific innovation and industry leadership. This approach offers employees a unique opportunity to be part of a pioneering team that drives real-world impacts across multiple sectors.

Company Stage

N/A

Total Funding

$6.4B

Headquarters

Cambridge, Massachusetts

Founded

2000

Simplify Jobs

Simplify's Take

What believers are saying

  • Flagship's recent $3.6 billion raise will support the creation of 25 new breakthrough companies, offering substantial growth opportunities.
  • The firm's track record of founding over 100 biotechnology companies, including industry leaders like Moderna, highlights its potential for high-impact innovation.
  • Key leadership appointments and promotions, such as Lovisa Afzelius to General Partner, strengthen Flagship's strategic direction and operational capabilities.

What critics are saying

  • The ambitious goal of creating 25 breakthrough companies may stretch resources and focus, potentially impacting the quality of each venture.
  • Heavy reliance on AI and advanced computational techniques could face technological and regulatory hurdles, slowing down progress.

What makes Flagship Pioneering unique

  • Flagship Pioneering's focus on creating and developing breakthrough companies in human health, sustainability, and AI sets it apart from traditional venture firms.
  • Their significant capital pool of $10.9 billion and $14 billion in assets under management provides unparalleled financial backing for innovative ventures.
  • Flagship's unique approach to leveraging generative AI for drug discovery and development accelerates the creation of transformative technologies.